Financial statements Globe Badania Kliniczne

Balance sheet of Globe Badania Kliniczne

Company age:
Age:
10 y. 4 m. 2 d.
Share capital:
Share capital:
18 000 PLN

Balance sheet data of GLOBE BADANIA KLINICZNE

Year
2018
2019
2020
2021
Total assets 102 422,98 80 100,63 167 370,39 218 527,11
A. Fixed assets 1 200,00 25 490,94 20 990,00 17 629,00
B. Current assets 101 222,98 54 609,69 146 380,39 200 898,11
C. Share capital contributions (basic funds) - - - -
D. Own shares (stocks) - - - -
Total liabilities 102 422,98 80 100,63 167 370,39 218 527,11
A. Equity 6 832,29 14 777,48 -15 632,29 32 101,71
B. Liabilities and provisions for liabilities 95 590,69 65 323,15 183 002,68 186 425,40
I. Long-term liabilities - - - -
II. Short-term liabilities 95 590,69 65 323,15 183 002,68 186 425,40
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.

  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.